Recent Advances and Outlook for the Isosteric Replacement of Anilines.
ACS Med Chem Lett, 2020/10/08;11(10):1785-1788.
Sodano TM[1], Combee LA[1], Stephenson CRJ[1]
Affiliations
PMID: 33062152DOI: 10.1021/acsmedchemlett.9b00687
Impact factor: 4.632
Abstract
Many promising drug candidates and pharmaceutical compounds fail due to idiosyncratic adverse drug reactions (IADRs), often arising from the formation of reactive metabolites. Among the "structural alerts" responsible, anilines are well-known to undergo deleterious metabolic processing, yet isosteric replacement strategies remain limited. Herein we discuss current art and potential new avenues of saturated isosteres to mitigate aniline-related toxicities.
More resources
Full text:
Europe PubMed Central; PubMed Central
EndNote: Download